{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:16:48Z","timestamp":1790302608701,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1074\/jbc.ra120.015352","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T03:45:38Z","timestamp":1607312738000},"page":"100163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-9751","authenticated-orcid":false,"given":"Emilie","family":"Ceraudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-2744","authenticated-orcid":false,"given":"Mizuho","family":"Horioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-9521","authenticated-orcid":false,"given":"Jordan M.","family":"Mattheisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3228-412X","authenticated-orcid":false,"given":"Tyler D.","family":"Hitchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3864-6387","authenticated-orcid":false,"given":"Amanda R.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-0827","authenticated-orcid":false,"given":"Manija A.","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0159-5531","authenticated-orcid":false,"given":"Ping","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0171-3884","authenticated-orcid":false,"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2836-8953","authenticated-orcid":false,"given":"Thomas P.","family":"Sakmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1844-262X","authenticated-orcid":false,"given":"Thomas","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA120.015352_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cell.2017.11.033","article-title":"Pharmacogenomics of GPCR drug targets","volume":"172","author":"Hauser","year":"2018","journal-title":"Cell"},{"key":"10.1074\/jbc.RA120.015352_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.RA120.015352_bib3","doi-asserted-by":"crossref","first-page":"D440","DOI":"10.1093\/nar\/gkx1109","article-title":"GPCRdb in 2018:\u00a0adding GPCR structure models and ligands","volume":"46","author":"Pandy-Szekeres","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1074\/jbc.RA120.015352_bib4","article-title":"The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)","author":"Chua","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/jbc.RA120.015352_bib5","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2018.01.081","article-title":"GNA11 Q209L Mouse model reveals RasGRP3 as an essential signaling Node in uveal melanoma","volume":"22","author":"Moore","year":"2018","journal-title":"Cell Rep."},{"key":"10.1074\/jbc.RA120.015352_bib6","article-title":"Combined Inhibition of G\u03b1q and MEK Enhances Therapeutic Efficacy in Uveal Melanoma","author":"Hitchman","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1074\/jbc.RA120.015352_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10014-018-0308-1","article-title":"Whole-exome sequencing of a meningeal melanocytic tumour reveals activating CYSLTR2 and EIF1AX hotspot mutations and similarities to uveal melanoma","volume":"35","author":"Kusters-Vandevelde","year":"2018","journal-title":"Brain Tumor Pathol."},{"key":"10.1074\/jbc.RA120.015352_bib8","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1074\/jbc.REV119.005601","article-title":"Illuminating the Onco-GPCRome: novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy","volume":"294","author":"Wu","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015352_bib9","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","article-title":"Characterization of the human cysteinyl leukotriene 2 receptor","volume":"275","author":"Heise","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015352_bib10","doi-asserted-by":"crossref","first-page":"eaan1210","DOI":"10.1126\/scisignal.aan1210","article-title":"Phosphatidylinositol 4-phosphate is a major source of\u00a0GPCR-stimulated phosphoinositide production","volume":"11","author":"de Rubio","year":"2018","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.RA120.015352_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1098\/rspb.1983.0093","article-title":"Operational models of pharmacological agonism","volume":"220","author":"Black","year":"1983","journal-title":"Proc. R. Soc. Lond. B Biol. Sci."},{"key":"10.1074\/jbc.RA120.015352_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tips.2019.01.002","article-title":"Can adding constitutive receptor activity Redefine biased signaling quantification?","volume":"40","author":"Zhou","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1074\/jbc.RA120.015352_bib13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1476-5381.2012.01901.x","article-title":"Development of operational models of receptor activation including constitutive receptor activity and their use to determine the efficacy of the chemokine CCL17 at the CC chemokine receptor CCR4","volume":"166","author":"Slack","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1074\/jbc.RA120.015352_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1124\/mol.110.069054","article-title":"Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT(2)) agonist, N-methyl-leukotriene C(4), in calcium reporter and beta arrestin assays","volume":"79","author":"Yan","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.RA120.015352_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/mol.116.105502","article-title":"CXC chemokine receptor 3 alternative Splice variants selectively activate different signaling pathways","volume":"90","author":"Berchiche","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1074\/jbc.RA120.015352_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"\u03b2-Arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu. Rev. Physiol."},{"key":"10.1074\/jbc.RA120.015352_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A\u00a0simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.RA120.015352_bib18","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1476-5381.2009.00604.x","article-title":"Ligand binding assays at equilibrium: validation and interpretation","volume":"161","author":"Hulme","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1074\/jbc.RA120.015352_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cell.2017.07.002","article-title":"Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors","volume":"170","author":"Zhou","year":"2017","journal-title":"Cell"},{"key":"10.1074\/jbc.RA120.015352_bib20","doi-asserted-by":"crossref","first-page":"32248","DOI":"10.1074\/jbc.274.45.32248","article-title":"Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization","volume":"274","author":"Oakley","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.RA120.015352_bib21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature14656","article-title":"Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser","volume":"523","author":"Kang","year":"2015","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.015352_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41594-019-0330-y","article-title":"Structure of an endosomal signaling GPCR-G protein-beta-arrestin megacomplex","volume":"26","author":"Nguyen","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1074\/jbc.RA120.015352_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature22070","article-title":"Selectivity determinants of GPCR-G-protein binding","volume":"545","author":"Flock","year":"2017","journal-title":"Nature"},{"key":"10.1074\/jbc.RA120.015352_bib24","doi-asserted-by":"crossref","first-page":"eaaw2778","DOI":"10.1126\/sciadv.aaw2778","article-title":"Multiplexed analysis of the secretin-like GPCR-RAMP interactome","volume":"5","author":"Lorenzen","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1074\/jbc.RA120.015352_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ab.2006.08.002","article-title":"D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation","volume":"358","author":"Trinquet","year":"2006","journal-title":"Anal Biochem."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582000157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582000157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA120.015352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T16:33:23Z","timestamp":1694190803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582000157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"alternative-id":["S002192582000157X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra120.015352","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/663153","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA120.015352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100163"}}